Scott Lippman

Scott Lippman is a Professor of Medicine at the University of California San Diego School of Medicine, with appointments in the Divisions of Hematology-Oncology and Bone Marrow Transplantation. His research spans cancer prevention, precision oncology, and immunotherapy with a particular focus on head and neck cancers and precancerous lesions.

Dr. Lippman's research interests center on molecular-based cancer prevention strategies, particularly for oral and head and neck cancers. He has pioneered work in chemoprevention, precancer biology, and the translation of molecular findings into clinical applications. His work has significantly contributed to understanding signaling vulnerabilities in cancer development and identifying targets for cancer interception.

His recent publications demonstrate a strong focus on precision oncology approaches, including molecular tumor boards for rare cancers, AI applications in cancer diagnostics, and understanding immune responses in cancer development. His work bridges basic science discoveries with clinical applications in cancer prevention and treatment.

Dr. Lippman has served as Principal Investigator on numerous NIH-funded research projects, including multiple R01 grants focused on oral cancer prevention and molecular-based therapy. His research has been continuously funded by the National Institutes of Health for decades, demonstrating the significance and impact of his work in the field of cancer prevention and precision medicine.